ATF4 and Alzheimer disease: We have previously reported that axonally synthesized ATF4 mediates pathogenic transcriptional changes and neurodegeneration triggered by soluble oligomeric Aβ42 (19, 20), a neurotoxic β-amyloid peptide linked to the onset of AD (1).